Caspase activity is essential for long-term potentiation

Journal of Neuroscience Research

Volumn 73, Issue 6, 2003, Pages 853-864

  Gulyaeva, Natalia V ^a   Kudryashov, Igor E ^a   Kudryashova, Irina V ^a  

^a INSTITUTE OF HIGHER NERVOUS ACTIVITY AND NEUROPHYSIOLOGY   (Russian Federation)

Author keywords

CA1; Caspase 3; Hippocampal slices; Long term potentiation (LTP); Z DEVD FMK

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3 INHIBITOR;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SUBSTRATE; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANIMALS; CALPAIN; CASPASE 3; CASPASES; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; ELECTRIC STIMULATION; ENZYME PRECURSORS; HIPPOCAMPUS; KETONES; LONG-TERM POTENTIATION; MALE; OLIGOPEPTIDES; RATS; TIME FACTORS;

EID: 0042338651     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10730     Document Type: Article

References (123)

1. Adam-Klages S, Schwandner R, Luschen S, Ussat S, Kreder D, Kronke M. 1998. Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis. J Immunol 161:5687-5694.
2. Ahmed BY, Yamaguchi F, Tsumura T, Gotoh T, Sugimoto K, Tai Y, Konishi R, Kobayashi R, Tokuda M. 2000. Expression and subcellular localization of multifunctional calmodulin-dependent protein kinases-I, -11 and -IV are altered in rat hippocampal CA1 neurons after induction of long-term potentiation. Neurosci Lett 290:149-153.
3. Allen JW, Knoblach SM, Faden AI. 1999. Combined mechanical trauma and metabolic impairment in vitro induces NMDA receptor-dependent neuronal cell death and caspase-3-dependent apoptosis. FASEB J 13:1875-1882.
4. Aronica E, Casabona G, Genazzani AA, Catania MV, Contestabile A, Virgili M, Nicoletti F. 1992. Melittin enhances excitatory amino acid release and AMPA-stimulated 45Ca2+ influx in cultured neurons. Brain Res 586:72-77.
5. Atsumi G, Murakami M, Kojima K, Hadano A, Tajima M, Kudo I. 2000. Distinct roles of two intracellular phospholipase A2s in fatty acid release in the cell death pathway. Proteolytic fragment of type IVA cytosolic phospholipase A2alpha inhibits stimulus-induced arachidonate release, whereas that of type VI Ca2+-independent phospholipase A2 augments spontaneous fatty acid release. J Biol Chem 275:18248-18258.
6. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
7. Chabot C, Gagne J, Giguere C, Bernard J, Baudry M, Massicotte G. 1998. Bidirectional modulation of AMPA receptor properties by exogenous phospholipase A2 in the hippocampus. Hippocampus 8:299-309.
8. Chan SL, Griffin WS, Mattson MP. 1999. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease. J Neurosci Res 57:315-323.
9. Chan SL, Mattson MP. 1999. Caspase and calpain substrates: roles in synaptic plasticity and cell Death. J Neurosci Res 58:167-190.
10. Chen J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH, Simon RP. 1998. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 18:4914-4928.
11. Colley PA, Routtenberg A. 1993. Long-term potentiation as synaptic dialogue. Brain Res Brain Res Rev 18:115-122.
12. Collins DR, Smith RC, Davies SN. 1995. Interactions between arachidonic acid and metabotropic glutamate receptors in the induction of synaptic potentiation in the rat hippocampal slice. Eur J Pharmacol 294:147-154.
13. Dash PK, Blum S, Moore AN. 2000. Caspase activity plays an essential role in long-term memory. Neuroreport 11:2811-2816.
14. Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F. 2000. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin 1 on amyloid biochemistry and pathology in APP/London mice. Exp Gerontol 35:831-841.
15. Dewachter I, Reverse D, Caluwaerts N, Ris L, Kuiperi C, Van den Haute C, Spittaels K, Umans L, Serneels L, Thiry E, Moechars D, Mercken M, Godaux E, Van Leuven F. 2002. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V7171] transgenic mice. J Neurosci 22:3445-3453.
16. Earnshaw WC, Martins LM, Kaufmann SH. 1999. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424.
17. Fadeel B, Orrenius S, Zhivotovsky B. 2000. The most unkindest cut of all: on the multiple roles of mammalian caspases. Leukemia 14:1514-1525.
18. Farooqui AA, Yang HC, Rosenberger TA, Horrocks LA. 1997. Phospholipase A2 and its role in brain tissue J. Neurochem 69:889-901.
19. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. 2002. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci USA 99:11025-11030.
20. Fitzjohn SM, Morton RA, Kuenzi F, Davies CH, Seabrook GR, Collingridge GL. 2000. Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices. Neurosci Lett 288:9-12.
21. Frutos S, Moscat J, Diaz-Meco MT. 1999. Cleavage of zetaPKC but not lambda/iota PKC by caspase-3 during UV-induced apoptosis. J Biol Chem 274:10765-10770.
22. Fujii S, Matsumoto M, Igarashi K, Kato H, Mikoshiba K. 2000. Synaptic plasticity in hippocampal CA1 neurons of mice lacking type 1 inositol-1,4,5-trisphosphate receptors. Learn Mem 7:312-320.
23. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, Matsuki N. 2001. Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase A(2) inhibitor in rat hippocampal slices. Br J Pharmacol 132:1417-1422.
24. Fukunaga K, Muller D, Ohmitsu M, Bako E, DePaoli-Roach AA, Miyamoto E. 2000. Decreased protein phosphatase 2A activity in hippocampal long-term potentiation. J Neurochem 74:807-817.
25. Gervais FG, Thornberry NA, Ruffolo SC, Nicholson DW, Roy S. 1998. Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide. J Biol Chem 273:17102-17108.
26. Gilman CP, Mattson MP. 2002. Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility? Neuromolecular Med 2:197-214.
27. Glazner GW, Chan SL, Lu C, Mattson MP. 2000. Caspase-mediated degradation of AMPA receptor subunits: a mechanism for preventing excitotoxic necrosis and ensuring apoptosis. J Neurosci 20:3641-3649.
28. Goosens KA, Maren S. 2002. Long-term potentiation as a substrate for memory: evidence from studies of amygdaloid plasticity and Pavlovian fear conditioning. Hippocampus 12:592-599.
29. Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. 1992. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science 258:1903-1910.
30. Grossmann J, Artinger M, Grasso AW, Kung HJ, Scholmerich J, Fiocchi C, Levine AD. 2001. Hierarchical cleavage of focal adhesion kinase by caspases alters signal transduction during apoptosis of intestinal epithelial cells. Gastroenterology 120:79-88.
31. Guttmann RP, Baker DL, Seifert KM, Cohen AS, Coulter DA, Lynch DR. 2001. Specific proteolysis of the NR2 subunit at multiple sites by calpain. J Neurochem 78:1083-1093.
32. Harris AS, Morrow JS. 1988. Proteolytic processing of human brain alpha spectrin (fodrin): identification of a hypersensitive site. J Neurosci 8:2640-2651.
33. Haug LS, Walaas SI, Ostvold AC. 2000. Degradation of the type I inositol 1,4,5-trisphosphate receptor by caspase-3 in SH-SY5Y neuroblastoma cells undergoing apoptosis. J Neurochem 75:1852-1861.
34. Hirota J, Furuichi T, Mikoshiba K. 1999. Inositol 1,4,5-trisphosphate receptor type 1 is a substrate for caspase-3 and is cleaved during apoptosis in a caspase-3-dependent manner. J Biol Chem 274:34433-34437.
35. Hrabetova S, Sacktor TC. 1996. Bidirectional regulation of protein kinase M zeta in the maintenance of long-term potentiation and long-term depression. J Neurosci 16:5324-5333.
36. Itoh S, Ito K, Fujii S, Kaneko K, Kato K, Mikoshiba K, Kato H. 2001. Neuronal plasticity in hippocampal mossy fiber-CA3 synapses of mice lacking the inositol-1,4,5-trisphosphate type 1 receptor. Brain Res 901:237-246.
37. Karni R, Levitzki A. 2000. pp60(cSrc) is a caspase-3 substrate and is essential for the transformed phenotype of A431 cells. Mol Cell Biol Res Commun 3:98-104.
38. Kasahara J, Fukunaga K, Miyamoto E. 2001. Activation of calcium/ calmodulin-dependent protein kinase IV in long-term potentiation in the rat hippocampal CA1 region. J Biol Chem 276:24044-24050.
39. Kato M, Nonaka T, Maki M, Kikuchi H, Imajoh-Ohmi S. 2000. Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat T cells. J Biochem (Tokyo) 127:297-305.
40. Kim CH, Lisman JE. 1999. A role of actin filament in synaptic transmission and long-term potentiation. J Neurosci 19:4314-4324.
41. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE. 1997. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277:373-376.
42. Kim YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel KB, Qin ZH, Aronin N, DiFiglia M. 2001. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci USA 98:12784-12789.
43. Kleschevnikov AM, Routtenberg A. 2001. PKC Activation rescues LTP from NMDA receptor blockade. Hippocampus 11:168-175.
44. Kojima N, Wang J, Mansuy IM, Grant SG, Mayford M, Kandel ER. 1997. Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc Natl Acad Sci USA 94:4761-4765.
45. Kondratyev A, Gale K. 2000. Intracerebral injection of caspase-3 inhibitor prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Brain Res Mol Brain Res 75:216-224.
46. Krucker T, Siggins GR, Halpain S. 2000. Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. Proc Natl Acad Sci USA 97:6856-6861.
47. Kudryashov IE, Onufriev MV, Kudryashova IV, Gulyaeva NV. 2001. Periods of postnatal maturation of hippocampus: synaptic modifications and neuronal disconnection. Brain Res Dev Brain Res 132:113-120.
48. Kudryashov IE, Yakovlev AA, Kudryashova I, Gulyaeva NV. 2002. Foot-shock stress alters early postnatal development of electrophysiological responses and caspase-3 activity in rat hippocampus. Neurosci Lett 332:95-98.
49. Lauri SE, Taira T, Rauvala H. 2000. High-frequency synaptic stimulation induces association of fyn and c-src to distinct phosphorylated components. Neuroreport 11:997-1000.
50. Ling DSF, Benardo LS, Serrano PA, Blace N, Kelly MT, Crary JF, Sacktor TC. 2002. Protein kinase Mzeta is necessary and sufficient for LTP maintenance. Nat Neurosci 5:295-296.
51. Loetscher H, Deuschle U, Brockhaus M, Reinhardt D, Nelboeck P, Mous J, Grunberg J, Haass C, Jacobsen H. 1997. Presenilins are processed by caspase-type proteases. J Biol Chem 272:20655-20659.
52. Los M, Stroh C, Janicke RU, Engels IH, Schulze-Osthoff K. 2001. Caspases: more than just killers? Trends Immunol 22:31-34.
53. Lu C, Fu W, Salvesen GS, Mattson MP. 2002. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuromolecular Med 1:69-79.
54. Lu X, Wyszynski M, Sheng M, Baudry M. 2001. Proteolysis of glutamate receptor-interacting protein by calpain in rat brain: implication for synaptic plasticity. J Neurochem 77:1553-1560.
55. Lu YF, Kojima N, Tomizawa K, Moriwaki A, Matsushita M, Obata K, Matsui H. 1999. Enhanced synaptic transmission and reduced threshold for LTP induction in fyn-transgenic mice. Eur J Neurosci 11:75-82.
56. Lu YM, Roder JC, Davidow J, Salter MW. 1998. Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science 279:1363-1367.
57. Luciano F, Ricci JE, Auberger P. 2001. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation. Oncogene 20:4935-4941.
58. Lynch G. 1998. Memory and the brain: unexpected chemistries and a new pharmacology. Neurobiol Learn Mem 70:82-100.
59. Lynch G, Baudry M. 1987. Brain spectrin, calpain and long-term changes in synaptic efficacy. Brain Res Bull 18:809-815.
60. Lynch G, Muller D, Seubert P, Larson J. 1988. Long-term potentiation: persisting problems and recent results. Brain Res Bull 21:363-372.
61. Ma J, Qiu J, Hirt L, Dalkara T, Moskowitz MA. 2001. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia. Br J Pharmacol 133:345-350.
62. Ma Z, Turk J. 2001. The molecular biology of the group VIA Ca2+-independent phospholipase A2. Prog Nucleic Acid Res Mol Biol 67:1-33.
63. Malenka RC, Kauer JA, Perkel DJ, Mauk MD, Kelly PT, Nicoll RA, Waxham MN. 1989. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 340:554-557.
64. Malinow R, Madison DV, Tsien RW. 1988. Persistent protein kinase activity underlying long-term potentiation. Nature 335:820-824.
65. Martin SJ, Morris RGM. 2002. New life in an old idea: the synaptic plasticity and memory hypothesis revisited. Hippocampus 12:609-636.
66. Massicotte G, Vanderklish P, Lynch G, Baudry M. 1991. Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation? Proc Natl Acad Sci USA 88:1893-1897.
67. Massicotte G. 2000. Modification of glutamate receptors by phospholipase A2: its role in adaptive neural plasticity. Cell Mol Life Sci 57:1542-1550.
68. Mattson MP. 2000. Apoptotic and anti-apoptotic synaptic signaling mechanisms. Brain Pathol 10:300-312.
69. Mattson MP, Duan W. 1999. "Apoptotic" biochemical cascades in synaptic compartments: roles in adaptive plasticity and neurodegenerative disorders. J Neurosci Res 58:152-166.
70. Mattson MP, Keller JN, Begley JG. 1998. Evidence for synaptic apoptosis. Exp Neurol 153:35-48.
71. Mattson MP, Liu D. 2002. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med 2:215-231.
72. McGinnis KM, Whitton MM, Gnegy ME, Wang KK. 1998. Calcium/ calmodulin-dependent protein kinase IV is cleaved by caspase-3 and calpain in SH-SY5Y human neuroblastoma cells undergoing apoptosis. J Biol Chem 273:19993-20000.
73. McLaughlin B, Hartnett KA, Erhardt JA, Legos JJ, White RF, Barone FC, Aizenman E. 2003. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci USA 100:715-720.
74. Mikoshiba K. 2002. [IP3 receptor, a Ca2+ oscillator - role of IP3 receptor in development and neural plasticity]. Japanese. Nippon Yakurigaku Zasshi 120:6-10.
75. Ming X, Li W, Maeda Y, Blumberg B, Raval S, Cook SD, Dowling PC. 2002. Caspase-1 expression in multiple sclerosis plaques and cultured glial cells. J Neurol Sci 197:9-18.
76. Miyamoto E, Fukunaga K, Takeuchi Y, Yamamoto H, Kasahara J, Liu J. 2002. [Calcium signaling and brain functions]. Japanese. Nippon Yakurigaku Zasshi 120:1-5.
77. Morton RA, Kuenzi FM, Fitzjohn SM, Rosahl TW, Smith D, Zheng H, Shearman M, Collingridge GL, Seabrook GR. 2002. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1. Neurosci Lett 319:37-40.
78. Moshnikova AB, Onufriev MV, Afanasyev VN, Zhukova AA, Gulyaeva NV, Beletsky IP. 2003. Analysis of nuclease activities in dying and differentiating U-937 cells. Mol Med (Rus) 1:52-58.
79. Muller D, Molinari I, Soldati L, Bianchi G. 1995. A genetic deficiency in calpastatin and isovalerylcarnitine treatment is associated with enhanced hippocampal long-term potentiation. Synapse 19:37-45.
80. Naik MU, Benedikz E, Hernandez I, Libien J, Hrabe J, Valsamis M, Dow-Edwards D, Osman M, Sacktor TC. 2000. Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol 426:243-258.
81. Nakazawa T, Tezuka T, Yamamoto T. 2002. [Regulation of NMDA receptor function by Fyn-mediated tyrosine phosphorylation]. Nihon Shinkei Seishin Yakurigaku Zasshi 22:165-167.
82. Nishizuka Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9:484-496.
83. Pamantung TF, Fontaine M, Fournier A, Vaudry D, Gonzalez BJ, Basille M, Vaudry H. 2000. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3yCPP32. Proc Natl Acad Sci USA 97:6398-6403.
84. Parent A, Linden DJ, Sisodia SS, Borchelt DR. 1999. Synaptic transmission and hippocampal long-term potentiation in transgenic mice expressing FAD-linked presenilin 1. Neurobiol Dis 6:56-62.
85. Pasinelli P, Ramakers GM, Urban IJ, Hens JJ, Oestreicher AB, de Graan PN, Gispen WH. 1995. Long-term potentiation and synaptic protein phosphorylation. Behav Brain Res 66:53-59.
86. Paulsen O, Morris RGM. 2002. Flies put the buzz back into long-term-potentiation. Nature Neurosci 5:289-290.
87. Pike BR, Flint J, Dutta S, Johnson E, Wang KK, Hayes RL. 2001. Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J Neurochem 78:1297-1306.
88. Porn-Ares MI, Samali A, Orrenius S. 1998. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ 5:1028-1033.
89. Popescu BO, Cedazo-Minguez A, Popescu LM, Winblad B, Cowburn RF, Ankarcrona M. 2001. Caspase cleavage of exon 9 deleted presenilin-1 is an early event in apoptosis induced by calcium ionophore A 23187 in SH-SY5Y neuroblastoma cells. J Neurosci Res 66:122-134.
90. Robertson JD, Zhivotovsky B. 2002. New methodology is a key to progress. Cell Cycle 1:119-121.
91. Rossiter JP, Anderson LL, Yang F, Cole GM. 2000. Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies. Neuropathol Appl Neurobiol 26:342-346.
92. Sacktor TC, Schwartz JH. 1993. Sensitizing stimuli cause translocation of protein kinase C in Aplysia sensory neurons. Proc Natl Acad Sci USA 90:8342-8346.
93. Salvesen GS. 2002. Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 9:3-5.
94. Sanchez Mejia RO, Friedlander RM. 2001. Caspases in Huntington's disease. Neuroscientist 7:480-489.
95. Santoro MF, Annand RR, Robertson MM, Peng YW, Brady MJ, Mankovich JA, Hackett MC, Ghayur T, Walter G, Wong WW, Giegel DA. 1998. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem 273:13119-13128.
96. Sasaki H, Kotsuji F, Tsang BK. 2002. Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein. Gynecol Oncol 85:339-350.
97. Sazontova TG, Matskevich AA, Arkhipenko YV. 1999. Calpains: physiological and pathophysiological significance. Pathophysiology 6:91-102.
98. Schneider I, Reverse D, Dewachter I, Ris L, Caluwaerts N, Kuiperi C, Gilis M, Geerts H, Kretzschmar H, Godaux E, Moechars D, Van Leuven F, Herms J. 2001. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J Biol Chem 276:11539-11544.
99. Schwartz JH, Greenberg SM. 1987. Molecular mechanisms for memory: second-messenger induced modifications of protein kinases in nerve cells. Annu Rev Neurosci 10:459-476.
100. See V, Boutillier AL, Bito H, Loeffler JP. 2001. Calcium/calmodulin-dependent protein kinase type IV (CaMKIV) inhibits apoptosis induced by potassium deprivation in cerebellar granule neurons. FASEB J 15:134-144.
101. Sessoms JS, Chen SJ, Chetkovich DM, Powell CM, Roberson ED, Sweatt JD, Klann E. 1992. Ca(2+)-induced persistent protein kinase C activation in rat hippocampal homogenates. Second Messengers Phosphoproteins 14:109-126.
102. Shi Y, Melnikov VY, Schrier RW, Edelstein CL. 2000. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am J Physiol Renal Physiol 279:509-517.
103. Shimohama S, Tanino H, Fujimoto S. 2001a. Differential expression of rat brain caspase family proteins during development and aging. Biochem Biophys Res Commun 289:1063-1066.
104. Shimohama S, Tanino H, Fujimoto S. 2001b. Differential subcellular localization of caspase family proteins in the adult rat brain. Neurosci Lett 315:125-128.
105. Skeberdis VA, Lan J, Opitz T, Zheng X, Bennett MV, Zukin RS. 2001. mGluR1-mediated potentiation of NMDA receptors involves a rise in intracellular calcium and activation of protein kinase C. Neuropharmacology 40:856-865.
106. Su JH, Kesslak JP, Head E, Cotman CW. 2002. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol (Berl) 104:1-6.
107. Tokuda M, Ahmed BY, Lu YF, Matsui H, Miyamoto O, Yamaguchi F, Konishi R, Hatase O. 1997. Involvement of calmodulin-dependent protein kinases-I and -IV in long-term potentiation. Brain Res 755:162-166.
108. Tomimatsu Y, Idemotoa S, Moriguchia S, Watanabe S, Nakanishia H. 2002. Proteases involved in long-term potentiation. Life Sci 72:355-361.
109. Troy CM, Salvesen GS. 2002. Caspases on the brain. J Neurosci Res 69:145-150.
110. Usdin MT, Shelbourne PF, Myers RM, Madison DV. 1999. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum Mol Genet 8:839-846.
111. van de Craen M, de Jonghe C, van den Brande I, Declercq W, van Gassen G, van Criekinge W, Vanderhoeven I, Fiers W, van Broeckhoven C, Hendriks L, Vandenabeele P. 1999. Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEBS Lett 445:149-154.
112. van de Water B, Nagelkerke JF, Stevens JL. 1999. Dephosphorylation of focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated cleavage of FAK during apoptosis in renal epithelial cells. J Biol Chem 274:13328-13337.
113. Wang KK, Posmantur R, Nadimpalli R, Nath R, Mohan P, Nixon RA, Talanian RV, Keegan M, Herzog L, Allen H. 1998. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch Biochem Biophys 356:187-196.
114. Wang Y, Mattson MP, Furukawa K. 2002. Endoplasmic reticulum calcium release is modulated by actin polymerization. J Neurochem 82:945-952.
115. Wellington CL, Leavitt BR, Hayden MR. 2000. Huntington disease: new insights on the role of huntingtin cleavage. J Neural Transm Suppl 58:1-17.
116. Wheal HV, Chen Y, Mitchell J, Schachner M, Maerz W, Wieland H, Van Rossum D, Kirsch J. 1998. Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticity. Prog Neurobiol 55:611-640.
117. Wolf MJ, Izumi Y, Zorumski CF, Gross RW. 1995. Long-term potentiation requires activation of calcium-independent phospholipase A2. FEBS Lett 377:358-362.
118. Wolf BB, Green DR. 1999. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274:20049-20052.
119. Woo NH, Abel T, Nguyen PV. 2002. Genetic and pharmacological demonstration of a role for cyclic AMP-dependent protein kinase-mediated suppression of protein phosphatases in gating the expression of late LTP. Eur J Neurosci 16:1871-1876.
120. Woo NH, Nguyen PV. 2002. "Silent" metaplasticity of the late phase of long-term potentiation requires protein phosphatases. Learn Mem 9:202-213.
121. Yan XX, Najbauer J, Woo CC, Dashtipour K, Ribak CE, Leon M. 2001. Expression of active caspase-3 in mitotic and postmitotic cells of the rat forebrain. J Comp Neurol 433:4-22.
122. Yuan J, Yankner BA. 2000. Apoptosis in the nervous system. Nature 407:802-809.
123. Zubkov AY, Aoki K, Parent AD, Zhang JH. 2002. Preliminary study of the effects of caspase inhibitors on vasospasm in dog penetrating arteries. Life Sci 70:3007-3018.